Arrow International central venous catheter kits recalled for contaminated anesthetic and saline components
Arrow International CVC kits recalled for contaminated anesthetic
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple central venous catheter kits. The supplier's components may not be sterile or effective, which could cause serious infection or treatment failure in patients receiving these kits.
- Check if your facility received any of the affected kit models listed in the recall notice.
- Do not use kits matching the recalled lot numbers.
- Contact Arrow International or the FDA for instructions on replacement or return.
- Review patient records if these kits were used and report any signs of infection to the patient's healthcare provider.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2384-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief